Cepheid (CPHD)

52.69
0.06 0.11
NASDAQ : Technology
Prev Close 52.63
Open 52.62
Day Low/High 52.56 / 52.78
52 Wk Low/High 25.09 / 58.85
Volume 1.54M
Avg Volume 1.89M
Exchange NASDAQ
Shares Outstanding 73.01M
Market Cap 3.84B
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cepheid...

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cepheid...

Cepheid (CPHD) Stock Downgraded to 'Neutral' at Baird

Cepheid (CPHD) Stock Downgraded to 'Neutral' at Baird

Cepheid's (CPHD) stock rating was cut to 'neutral' at Baird on Monday morning.

CEPHEID SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Cepheid (CPHD) Over the Proposed Sale of the Company to Danaher Corporation

CEPHEID SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Cepheid (CPHD) Over the Proposed Sale of the Company to Danaher Corporation

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Cepheid

Cepheid Targets Development Of A Point Of Care HIV Viral Load Test From A Few Drops Of Blood

Cepheid Targets Development Of A Point Of Care HIV Viral Load Test From A Few Drops Of Blood

Enabling Accurate and Fast Molecular HIV Viral Load Test from Finger Stick Whole Blood

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cepheid...

Cepheid (CPHD) Stock Price Target Raised at Barclays on Danaher Deal

Cepheid (CPHD) Stock Price Target Raised at Barclays on Danaher Deal

Barclays hiked Cepheid's (CPHD) stock price target to $52 on Wednesday after Danaher (DHR) agreed to buy the company for $4 billion yesterday.

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.

Jim Cramer's 'Mad Money' Recap: These Stocks Will Rise, Whatever the Fed Does

Jim Cramer's 'Mad Money' Recap: These Stocks Will Rise, Whatever the Fed Does

Mergers and high-growth stocks are making the market better and better, Cramer says.

Cepheid's Xpert TV Now Cleared For Testing Symptomatic And Asymptomatic Men

Cepheid's Xpert TV Now Cleared For Testing Symptomatic And Asymptomatic Men

First and Only Trichomonas NAAT Test with Male Urine Claims Cleared for Use in United States

Stocks See Slight Gains as September Rate Hike Chances Shrink

Stocks See Slight Gains as September Rate Hike Chances Shrink

Weaker chances of a rate hike when the Federal Reserve meets in two weeks left Wall Street in a bright mood on its return from the long Labor Day weekend.

Cramer: Stocks That Defy the Fed's Gravitational Pull

Cramer: Stocks That Defy the Fed's Gravitational Pull

These names show the downward pull can be beaten with the right set of circumstances, and it happens more often than you might think.

Stocks Hold Slight Gains Amid Weaker U.S. Services Activity, Oil Rises

Stocks Hold Slight Gains Amid Weaker U.S. Services Activity, Oil Rises

Stocks hold slight gains through to mid-afternoon Tuesday after weaker U.S. services activity pushes back the chances of a September interest rate hike.

CEPHEID SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Danaher Corporation

CEPHEID SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Danaher Corporation

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Cepheid...

Cepheid (CPHD) Stock Surges, to be Acquired by Danaher for $4 Billion

Cepheid (CPHD) Stock Surges, to be Acquired by Danaher for $4 Billion

Danaher (DHR) said on Tuesday that it will purchase Cepheid (CPHD) for $4 billion in cash.

Stocks Turn Mixed as Services Activity Sees Slowest Growth Since 2010

Stocks Turn Mixed as Services Activity Sees Slowest Growth Since 2010

Stocks hold mixed by mid-morning Tuesday after U.S. services activity last month declines more than expected.

Stock Futures Edge Higher as Wall Street Mulls Fed's Next Move

Stock Futures Edge Higher as Wall Street Mulls Fed's Next Move

Stock futures edge higher in the return from the long Labor Day weekend as markets continue to mull over the Federal Reserve's next big move.

Danaher Bolsters Diagnostics Business With Cepheid Purchase

Danaher Bolsters Diagnostics Business With Cepheid Purchase

The recently slimmed-down buyer will pay $4 billion including debt for the molecular diagnostics specialist.

Insider Trading Alert - CPHD, WM And RTEC Traded By Insiders

Insider Trading Alert - CPHD, WM And RTEC Traded By Insiders

Stocks with insider trader activity include CPHD, WM and RTEC